Biolase (BIOLQ) 10-Q2003 Q2 Quarterly report

Filed: 17 Sep 03, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade V good

New words: accelerate, adapt, adequacy, ADL, AG, alter, announcement, annum, approach, assume, assumed, Assuming, authorize, authorized, bear, behalf, BL, borrow, borrowed, brand, breach, brought, BSI, burdened, Canada, channel, characterized, classify, clause, Collete, comfort, communicated, component, ConBio, conceived, covenant, Cozean, criminal, crystal, culture, cure, damage, declaratory, default, deficit, Deka, difficulty, Diolase, directly, dispersed, Disposal, drawn, effort, EITF, employee, enjoined, explained, FASB, faster, fiber, finite, Fotona, found, founded, fourteen, fulfill, furnish, furnished, gel, geographically, good, grown, guaranty, guidance, half, handle, herewith, high, Hoya, ii, implementing, impose, incremental, incurrence, indefinite, indeterminate, instrument, interruption, Japanese, labeling, lender, liable, likelihood, main, margin, matter, minimal, modified, multiple, notice, notified, November, NTL, objective, OpusDent, originally, overhead, Oxley, paid, pain, paragraph, permanent, portfolio, power, proceeding, produce, promotion, promulgated, prosecution, Pulsemaster, Qualitative, Quantitative, quota, quoted, ratio, recall, receipt, recruit, relationship, release, remotely, requested, response, responsible, restate, restated, restatement, Rule, seizure, separate, shutdown, sought, specific, sponsored, standard, standardized, stayed, storage, strategic, Submission, succeed, suffer, superior, supervision, suspension, tangible, taxable, thereunto, tied, title, training, treble, uncompetitive, undersigned, unspecified, variable, viability, vigorously, West, wide, worth, written

Removed: advanced, approval, approved, attention, began, blank, check, commercialization, conformity, contest, conversion, daily, delisted, demonstrate, dentistry, diagnostic, divert, existence, extreme, generating, installment, lesser, listed, listing, local, marketability, measurable, noncompetitive, obtainable, October, offer, opted, pharmaceutical, phase, point, proxy, public, pursuing, reach, refinance, remaining, resolution, shipped, sustained, takeover, therapeutic, trading, unrelated, volatile

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

BIOLQ similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002*

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Edson J. Rood, Chief Financial Officer of BioLase Technology, Inc. (the “Company”), hereby certify that to my knowledge:

(1)

The quarterly report on Form 10-Q for the quarter ended June 30, 2003 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: September 16, 2003				/s/ EDSON J. ROOD
				Edson J. Rood
				Chief Financial Officer

* This certificate accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.